IMMUNIDEX™
The Immunidex™ is an indication of the patient’s T-Lymphoproliferative response to mitogen stimulation relative to the response of a control population. An average or weakened immune response may improve with correction of the nutritional deficiencies determined by the micoronutrient testing.
Specifically, the Immunidex™ is an indicator of how well a person’s lymphocytes respond to challenges from either the environment or potential disease burdens. In other words, if the Immunidex™ is high, the person had a stronger immune response. The Immunidex™ score uses a patented technology for assessing cellular function, unique to SpectraCell Laboratories. As a result, no other lab offers this type of indicator. “When people think immunity, they think colds and infections. But cell-mediated immune function is a major defense against degenerative disease like heart disease, cancer and arthritis.” states Dr. Fred Crawford, PhD, Vice President and Director of Operations for SpectraCell Laboratories. “And since nutritional deficiencies profoundly impact a person’s immune function, including it on the micronutrient test report makes perfect sense. Correct your deficiencies, and in the majority of patients, immune function improves.” Each person responds to an immune challenge differently. Younger people usually have a stronger immune response than the elderly. Those with fewer, or less severe, nutritional deficiencies also will typically have healthier immune responses. In addition, a person’s ability to fight oxidative stress in their bodies is correlated with healthy immune function. Spectrox™, which measures a person’s response to oxidative stress and is also included on their micronutrient test, often correlates with Immunidex™ so that that higher the Spectrox™ score, the higher the Immunidex™ and vice versa.
Clinical Updates on IMMUNIDEX™
